18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

Clinical trial NCT07077213 · RECRUITING

Trial details

NCT number: NCT07077213
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: RECRUITING
Study type: OBSERVATIONAL

Tuberculosis, Pulmonary

Start date: 2026-03-12
Primary completion: 2027-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.